Aug 2026
Loss of PBRM1 accelerates pancreatic cancer progression by inducing acquisition of mesenchymal phenotype and inflammatory cancer-associated fibroblasts reprogramming.
Findings indicated a tumor-suppressing role of PBRM1 in PDAC, which constitutes a specific subgroup of patients with aggressive phenotype and prognostic significance.
Jin Li, Risheng Que, Jian Zhang et al.
· Cancer Letters · 0 citations